How has been the historical performance of GPT Healthcare?

Answer:The historical performance of GPT Healthcare shows significant growth from March 2021 to March 2022.

Breakdown:
In the fiscal year ending March 2022, GPT Healthcare reported net sales of 337.42 Cr, an increase from 242.75 Cr in the previous year. Total operating income mirrored this growth, reaching 337.42 Cr compared to 242.75 Cr in March 2021. The total expenditure, excluding depreciation, rose to 263.58 Cr from 193.76 Cr, primarily driven by increased raw material costs and other expenses. Operating profit, excluding other income, improved to 73.84 Cr from 48.99 Cr, resulting in an operating profit margin of 21.88%, up from 20.18%. Profit before tax also saw a substantial rise to 54.08 Cr from 28.88 Cr, leading to a profit after tax of 41.66 Cr, compared to 21.09 Cr the previous year, which reflects a PAT margin increase to 12.35% from 8.69%. On the balance sheet, total liabilities increased to 319.51 Cr from 310.61 Cr, while total assets rose to the same figure, indicating stability. Cash flow from operating activities improved to 65.00 Cr from 42.00 Cr, contributing to a net cash inflow of 3.00 Cr, compared to 4.00 Cr in the prior year. Overall, GPT Healthcare demonstrated robust growth across key financial metrics in the reported period.